Literature DB >> 23461737

Sodium removal and peritoneal dialysis modalities: no differences with optimal prescription of icodextrin.

Costas Fourtounas1, Periklis Dousdampanis, Andreas Hardalias, Jannis G Vlachojannis.   

Abstract

Continuous ambulatory peritoneal dialysis (CAPD) has been considered as a more efficient modality for sodium removal than automated peritoneal dialysis (APD), due to the longer dwell times and the sodium sieving phenomenon. However, because studies regarding sodium removal in peritoneal dialysis (PD) report rather controversial results and carry various methodological flaws, it remains uncertain whether they offer enough significant information regarding PD prescription and therapy. The aim of the present observational cross-sectional study was to evaluate the impact of the optimal prescription of CAPD and APD, regarding solute clearances and daily ultrafiltrate, on daily sodium removal. Forty-six (46) patients aged 52.3 ± 14 years were studied. Twenty-six (26) patients were subjected to CAPD, and 20 patients were subjected to APD. Ten (10) patients per group were prescribed icodextrin for the long dwell to achieve optimal adequacy and ultrafiltration (UF) targets. CAPD patients removed a higher, albeit not statistically significant, daily amount of sodium (131.7 ± 98.2 mmol) compared with APD patients (79.4 ± 129.2 mmol). Their Kt/V urea was lower (1.48 ± 0.3 vs. 2.17 ± 0.33, P < 0.05), and there were no differences on daily UF (1119 ± 533 vs. 1005 ± 517 mL). In both groups, icodextrin use for the long dwell resulted in equal sodium removal with that of patients not prescribed icodextrin. Our results, derived from an unselected PD population, indicate that although classic CAPD may be more efficient for sodium removal than APD, the use of icodextrin as an adjuvant for higher daily UF not only increases solute clearance but also removes more sodium for both modalities. In addition, calculations of sodium removal in PD do not seem to benefit the everyday clinical practice, provided that PD patients can achieve the adequacy targets and present optimal daily UF without signs of volume overload.
© 2013, Copyright the Authors. Artificial Organs © 2013, International Center for Artificial Organs and Transplantation and Wiley Periodicals, Inc.

Entities:  

Keywords:  Icodextrin; Peritoneal dialysis; Sodium removal

Mesh:

Substances:

Year:  2013        PMID: 23461737     DOI: 10.1111/aor.12061

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  5 in total

1.  Sodium removal by peritoneal dialysis: a systematic review and meta-analysis.

Authors:  Silvio Borrelli; Vincenzo La Milia; Luca De Nicola; Gianfranca Cabiddu; Roberto Russo; Michele Provenzano; Roberto Minutolo; Giuseppe Conte; Carlo Garofalo
Journal:  J Nephrol       Date:  2018-07-05       Impact factor: 3.902

2.  Characterization of sodium removal to ultrafiltration volume in a peritoneal dialysis outpatient cohort.

Authors:  David A Jaques; Andrew Davenport
Journal:  Clin Kidney J       Date:  2020-04-06

Review 3.  Icodextrin and peritoneal dialysis: advantages and new applications.

Authors:  Periklis Dousdampanis; Carlos Guido Musso; Konstantina Trigka
Journal:  Int Urol Nephrol       Date:  2017-07-03       Impact factor: 2.370

4.  Renal Replacement Therapy: Purifying Efficiency of Automated Peritoneal Dialysis in Diabetic versus Non-Diabetic Patients.

Authors:  Nicanor Vega-Diaz; Fayna Gonzalez-Cabrera; Silvia Marrero-Robayna; Raquel Santana-Estupiñan; Roberto Gallego-Samper; Fernando Henriquez-Palop; Patricia Perez-Borges; José Carlos Rodriguez-Perez
Journal:  J Clin Med       Date:  2015-07-22       Impact factor: 4.241

Review 5.  APD or CAPD: one glove does not fit all.

Authors:  Athanasios Roumeliotis; Stefanos Roumeliotis; Konstantinos Leivaditis; Marios Salmas; Theodoros Eleftheriadis; Vassilios Liakopoulos
Journal:  Int Urol Nephrol       Date:  2020-10-13       Impact factor: 2.370

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.